The rising influence of a few dominant medication firms is sparking serious concerns worldwide. This trend towards monopolies regularly contributes to increased prescription prices, limited development, and challenges in receiving vital treatments for individuals in the globe. Researchers contend that stronger scrutiny is needed to address these ch

India's pharmaceutical landscape presents a complex picture, largely shaped by the substantial influence of a few dominant players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of sector concentration that warrants scrutiny. These incumbent companies, including names like Su